跳至主要内容
临床试验/CTRI/2024/07/070519
CTRI/2024/07/070519尚未招募Unknown

Assessment of visual outcome and quality of life during the course of treatment with intravitreal anti-VEGF injection in patients with diabetic macular edema. - NI

Ramanpreet Kaur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients with center involving diabetic macular edema requiring anti-VEGF injections
  • Patients who are already undergoing treatment with intravitreal anti-VEGF injections

排除标准

  • Patients with media opacities due to dense cataract , vitreous hemorrhage etc in whom it is difficult to assess posterior segment
  • Patients with recent stroke less than 3 months who cannot be injected anti-VEGF
  • Patient with other chronic comorbidities example inability to walk , hearing loss or visual loss due to causes other than DME that may affect quality of life
  • Patients undergoing other intravitreal injections like steroids
  • Patients who are not able to have adequate hearing and sight cognition to be able to complete interview questions

研究者

发起方
Ramanpreet Kaur

相似试验